# Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults

> **NCT00183729** · PHASE4 · COMPLETED · sponsor: **Eric Lenze** · enrollment: 35 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Memantine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00183729
- **Lead sponsor:** Eric Lenze
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2018-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183729, "Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00183729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*